Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 15

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 169–180 of 391 articles

High impact AnalysisJun 2, 2026

DCAT Week 2024: Strategic Imperatives for Pharma BD and Investors

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Leadership Vacuum: Navigating Uncertainty for Pharmaceutical Business Development

FDA · 9 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

BMS-Hengrui $15B Deal: Strategic Implications for Pharma Executives

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

FDA Cracks Down on Illegal Tobacco Products Disguised as Everyday Items

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Biogen Faces Italian Antitrust Probe: What It Means for the Multiple Sclerosis Market

FDA · multiple sclerosis · 10 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

FDA Draft Guidance Slashes Biosimilar PK Study Costs, Accelerating Market Entry

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Eli Lilly Dominates Pharma R&D Performance Rankings, Setting New Benchmarks

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Eli Lilly's Strategic Vaccine Acquisitions: A New Era in Infectious Disease

FDA · vaccine · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

TrumpRx Expands Generic Drug Offerings: Implications for Pharma BD and Investors

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Supreme Court Upholds Medicare Drug Price Negotiation: Implications for Pharma

FDA · 8 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Longeveron Stockholder Letter Outlines 2026 Strategy and Partnership Focus

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Citius Pharmaceuticals Stock Update: Cancer and Anti-Infective Pipeline Insights

FDA · cancer · 11 min

Dr. Sarah Mitchell